Authors: MARAIS AD FIRTH JC BATEMAN ME BYRNES P MARTENS C MOUNTNEY J

Citation: Ad. Marais et al., ATORVASTATIN - AN EFFECTIVE LIPID-MODIFYING AGENT IN FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 17(8), 1997, pp. 1527-1531

Authors: MARAIS AD NAOUMOVA RP FIRTH JC PENNY C NEUWIRTH CKY THOMPSON GR

Citation: Ad. Marais et al., DECREASED PRODUCTION OF LOW-DENSITY-LIPOPROTEIN BY ATORVASTATIN AFTERAPHERESIS IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Journal of lipid research, 38(10), 1997, pp. 2071-2078

Authors: NAOUMOVA RP MARAIS AD MOUNTNEY J FIRTH JC RENDELL NB TAYLOR GW THOMPSON GR

Citation: Rp. Naoumova et al., PLASMA MEVALONIC ACID, AN INDEX OF CHOLESTEROL-SYNTHESIS IN-VIVO, ANDRESPONSIVENESS TO HMG-COA REDUCTASE INHIBITORS IN FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 119(2), 1996, pp. 203-213

Authors: NAOUMOVA RP MARAIS D FIRTH JC NEUWIRTH CKY TAYLOR GW THOMPSON GR

Citation: Rp. Naoumova et al., ATORVASTATIN AUGMENTS THERAPY OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA BY INHIBITING UP-REGULATION OF CHOLESTEROL-SYNTHESIS AFTER APHERESIS AND BILE-ACID SEQUESTRANTS, Circulation, 94(8), 1996, pp. 3410-3410

Authors: MARAIS AD WOOD L FIRTH JC HALL JM JACOBS P

Citation: Ad. Marais et al., PLASMA-EXCHANGE FOR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - THE CAPE-TOWN EXPERIENCE, Transfusion science, 14(3), 1993, pp. 239-247